PHA-739358 for the Treatment of Multiple Myeloma

NCT00872300 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
INDUSTRY
Sponsor class

Stopped Low recruitment rate

Conditions

Interventions

Sponsor

Nerviano Medical Sciences